vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.
Vitesse Energy, Inc. is the larger business by last-quarter revenue ($58.6M vs $38.3M, roughly 1.5× ImmunityBio, Inc.). Vitesse Energy, Inc. runs the higher net margin — -1.3% vs -161.8%, a 160.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 4.8%).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.
IBRX vs VTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $58.6M |
| Net Profit | $-61.9M | $-739.0K |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | -12.0% |
| Net Margin | -161.8% | -1.3% |
| Revenue YoY | 407.0% | 4.8% |
| Net Profit YoY | -4.7% | 85.6% |
| EPS (diluted) | $-0.06 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $58.6M | ||
| Q3 25 | $32.1M | $67.4M | ||
| Q2 25 | $26.4M | $81.8M | ||
| Q1 25 | $16.5M | $66.2M | ||
| Q4 24 | $7.6M | $55.9M | ||
| Q3 24 | $6.1M | $58.3M | ||
| Q2 24 | — | $66.6M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | $-61.9M | $-739.0K | ||
| Q3 25 | $-67.3M | $-1.3M | ||
| Q2 25 | $-92.6M | $24.7M | ||
| Q1 25 | $-129.6M | $2.7M | ||
| Q4 24 | $-59.2M | $-5.1M | ||
| Q3 24 | $-85.7M | $17.4M | ||
| Q2 24 | — | $10.9M | ||
| Q1 24 | — | $-2.2M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | -12.0% | ||
| Q3 25 | -173.5% | 0.2% | ||
| Q2 25 | -269.8% | 22.8% | ||
| Q1 25 | -390.1% | 8.1% | ||
| Q4 24 | -919.0% | 3.7% | ||
| Q3 24 | -1314.3% | 15.4% | ||
| Q2 24 | — | 25.2% | ||
| Q1 24 | — | 21.4% |
| Q4 25 | -161.8% | -1.3% | ||
| Q3 25 | -209.8% | -1.9% | ||
| Q2 25 | -350.3% | 30.2% | ||
| Q1 25 | -784.9% | 4.0% | ||
| Q4 24 | -783.4% | -9.2% | ||
| Q3 24 | -1404.0% | 29.9% | ||
| Q2 24 | — | 16.4% | ||
| Q1 24 | — | -3.6% |
| Q4 25 | $-0.06 | $-0.01 | ||
| Q3 25 | $-0.07 | $-0.03 | ||
| Q2 25 | $-0.10 | $0.60 | ||
| Q1 25 | $-0.15 | $0.08 | ||
| Q4 24 | $-0.08 | $-0.15 | ||
| Q3 24 | $-0.14 | $0.53 | ||
| Q2 24 | — | $0.33 | ||
| Q1 24 | — | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $629.3M |
| Total Assets | $501.9M | $893.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | — | ||
| Q3 25 | $257.8M | — | ||
| Q2 25 | $153.7M | — | ||
| Q1 25 | $61.6M | $4.5M | ||
| Q4 24 | $149.8M | $3.0M | ||
| Q3 24 | $130.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-500.5M | $629.3M | ||
| Q3 25 | $-524.3M | $650.3M | ||
| Q2 25 | $-570.7M | $671.9M | ||
| Q1 25 | $-591.4M | $667.7M | ||
| Q4 24 | $-489.1M | $500.3M | ||
| Q3 24 | $-745.1M | $520.4M | ||
| Q2 24 | — | $518.5M | ||
| Q1 24 | — | $522.7M |
| Q4 25 | $501.9M | $893.4M | ||
| Q3 25 | $519.0M | $932.9M | ||
| Q2 25 | $402.1M | $951.5M | ||
| Q1 25 | $303.8M | $975.2M | ||
| Q4 24 | $382.9M | $810.9M | ||
| Q3 24 | $364.6M | $791.2M | ||
| Q2 24 | — | $778.4M | ||
| Q1 24 | — | $749.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $37.4M |
| Free Cash FlowOCF − Capex | $-71.3M | — |
| FCF MarginFCF / Revenue | -186.2% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $37.4M | ||
| Q3 25 | $-68.9M | $49.4M | ||
| Q2 25 | $-79.7M | $66.0M | ||
| Q1 25 | $-85.9M | $17.5M | ||
| Q4 24 | $-85.1M | $34.7M | ||
| Q3 24 | $-98.8M | $45.7M | ||
| Q2 24 | — | $35.2M | ||
| Q1 24 | — | $39.4M |
| Q4 25 | $-71.3M | — | ||
| Q3 25 | $-69.6M | — | ||
| Q2 25 | $-80.8M | — | ||
| Q1 25 | $-87.0M | — | ||
| Q4 24 | $-87.3M | — | ||
| Q3 24 | $-101.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -186.2% | — | ||
| Q3 25 | -217.2% | — | ||
| Q2 25 | -305.9% | — | ||
| Q1 25 | -526.9% | — | ||
| Q4 24 | -1155.4% | — | ||
| Q3 24 | -1663.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 28.0% | — | ||
| Q3 24 | 45.7% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.68× | ||
| Q1 25 | — | 6.56× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.62× | ||
| Q2 24 | — | 3.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBRX
Segment breakdown not available.
VTS
| Oil Reserves | $54.5M | 93% |
| Natural Gas Reserves | $4.2M | 7% |
